Qualitative Study Patient & Physician Experiences Botox COVID-19
NCT05435404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2022-06-28
Summary
During the COVID-19 pandemic and subsequent series of Lockdowns, clinic out-patient spasticity services were replaced with video based tele-consultation appointments, in order to reduce the potential risk of virus transmission between patients and clinicians in either direction. This meant that for an extensive period of time, this treatment could not be offered, and like many other specialist services, this resulted in a backlog of case referrals and an extensive clinic waiting list, where patient appointments and referrals were delayed by the pandemic.
There have been discussions in many professional network forums that have suggested that the necessary changes to appointments during the pandemic may have contributed to a build-up of pain and disability for patients who were unable to access spasticity management treatment when they needed it.
This research aims to gain insight and understanding of the individual experiences and perceptions of patients, carers and a physician who have been involved in spasticity treatment out-patient service clinics during and post COVID 19 pandemic. To do this, a qualitative research approach has been adopted and a group of 10 potential participants along with one consultant physician will be invited to participate in the study.
Participants will be provided with information on the research (Participant Information Sheet) and asked to provide written informed consent (Consent Form) in order to take part.
After providing consent, the participant will be interviewed via telephone. Data will be analysed using a thematic approach by the research team to identify the challenges, opportunities and barriers that may have been encountered during the pandemic and post pandemic period. All participants will be provided with a debrief document.
Conditions
- Chronic Brain Injury
- Cerebral Stroke
- MS (Multiple Sclerosis)
Sponsors & Collaborators
-
East Kent Hospitals University NHS Foundation Trust
lead OTHER_GOV
Principal Investigators
-
Mohamed Dr Sakel, MBBS · East Kent Hospitals University NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-08
- Primary Completion
- 2022-04-30
- Completion
- 2022-04-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity
NCT01575054 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficiency of Botulinum Toxin Injection for Spastic Equinovarus Foot in Post Stroke Hemiparetic Patients
NCT03405948 ·Status: COMPLETED ·Phase: NA
-
BOTOX® Economic Spasticity Trial (BEST)
NCT00549783 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity.
NCT04396704 ·Status: COMPLETED
-
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
NCT00430196 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of BOTOX® With Rehabilitation Therapy for the Treatment of Wrist and Hand Spasticity in Post-Stroke Patients
NCT00565201 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity
NCT04036981 ·Status: COMPLETED
-
BOTOX® Treatment in Pediatric Lower Limb Spasticity
NCT01603628 ·Status: COMPLETED ·Phase: PHASE3
-
MDs on Botox Utility (MOBILITY)
NCT00535938 ·Status: COMPLETED
-
Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia
NCT03938363 ·Status: COMPLETED ·Phase: NA
-
Early Treatment of Post-stroke Spasticity With Botulinum Toxin
NCT04404868 ·Status: COMPLETED
-
Spasticity and Treatment Satisfaction Among Stroke Survivors
NCT03995524 ·Status: COMPLETED
-
Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait
NCT07108920 ·Status: RECRUITING
-
Interest of Immersive Virtual Reality on Stress During Botulinum Toxin Injections in Spasticity (RVTOX)
NCT05364203 ·Status: COMPLETED ·Phase: NA
-
The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity
NCT05887479 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
NCT05103202 ·Status: COMPLETED
-
Botox vs Occlusal Splint for Masseter Pain
NCT03456154 ·Status: COMPLETED ·Phase: PHASE4
-
Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
NCT01444794 ·Status: COMPLETED
-
Biomechanical and Neurophysiological Evaluation of the Effect of a Motor Block and an Injection of Botulinum Toxin on the Stiffness of the Paretic Sural Triceps Muscle
NCT04717141 ·Status: COMPLETED ·Phase: NA
-
Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles
NCT00133861 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
NCT01390922 ·Status: COMPLETED
-
Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
NCT00819065 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin A in the Treatment of Hemifacial Spasm
NCT03306940 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb Spasticity
NCT05382767 ·Status: COMPLETED ·Phase: PHASE1